JHMH:ARCA-John Hancock Multifactor Healthcare

ETF | Others | NYSE Arca

Last Closing

USD 34.313

Change

+0.06 (+0.16)%

Market Cap

USD 0.02B

Volume

400.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the John Hancock Dimensional Healthcare Index. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities that compose the fund's benchmark index. The index is designed to comprise securities in the healthcare sector within the U.S. Universe whose market capitalizations are larger than that of the 1001st largest U.S. Company at the time of reconstitution. The fund is non-diversified.

Inception Date: 28/09/2015

Primary Benchmark: JH Dimensional Healthcare TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 1.23%

Management Expense Ratio: 0.46 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

-0.08 (-0.39%)

USD 65.72B
ITDC Ishares Lifepath Target Date 2.. 0.00 %

+0.16 (+0.56%)

USD 36.86B
JEPI JPMorgan Equity Premium Income.. 0.00 %

+0.35 (+0.61%)

USD 32.78B
LCR Leuthold Core ETF 0.00 %

+0.22 (+0.66%)

USD 32.52B
DTB DTB 0.00 %

-0.30 (-1.44%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

+0.38 (+1.21%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

+0.02 (+0.04%)

USD 22.47B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.05 (+0.05%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear.. 0.00 %

+0.24 (+0.72%)

USD 16.23B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.63 (+1.57%)

USD 10.15B

ETFs Containing JHMH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.79% 39% F 38% F
Dividend Return 2.13% 85% B 64% D
Total Return 10.92% 43% F 39% F
Trailing 12 Months  
Capital Gain 3.01% 64% D 62% D
Dividend Return 2.45% 66% D+ 48% F
Total Return 5.46% 66% D+ 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 7.61% 61% D- 61% D-
Dividend Return 8.26% 54% F 58% F
Total Return 0.65% 37% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 7.53% 96% N/A 91% A-
Risk Adjusted Return 109.72% 93% A 95% A
Market Capitalization 0.02B 40% F 17% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.